[Application of HI-56 (ampicillin-dicloxacillin) to urological infections (author's transl)].
D000150:Acinetobacter / Q000187:drug effects; D000328:Adult; D000667:Ampicillin / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D004009:Dicloxacillin / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use; D004338:Drug Combinations; D004341:Drug Evaluation; D004926:Escherichia coli / Q000187:drug effects; D005260:Female; D006801:Humans; D007962:Leukocytes; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011513:Proteus mirabilis / Q000187:drug effects; D013124:Spinal Injuries / Q000150:complications; D001750:Urinary Bladder, Neurogenic / Q000188:drug therapy / Q000209:etiology; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D014556:Urine / Q000166:cytology
D004338:Drug Combinations; D000667:Ampicillin; D004009:Dicloxacillin